A novel and simple hollow-fiber assay for in vivo evaluation of nonpeptidyl thrombopoietin receptor agonists
- 31 May 2012
- journal article
- Published by Elsevier BV in Experimental Hematology
- Vol. 40 (5), 386-392
- https://doi.org/10.1016/j.exphem.2012.01.010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerationsDrug Design, Development and Therapy, 2010
- AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonistEuropean Journal of Haematology, 2009
- Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor AgonistThe International Journal of Cell Cloning, 2009
- Use of the in Vivo Hollow Fiber Assay in Natural Products Anticancer Drug DiscoveryJournal of Natural Products, 2009
- Thrombopoietin Mimetic Agents in the Management of Immune Thrombocytopenic PurpuraSeminars in Hematology, 2007
- A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesisBlood, 2006
- Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonistExperimental Hematology, 2005
- Recombinant human thrombopoietin: basic biology and evaluation of clinical studiesBlood, 2002
- Thrombocytopenia caused by the development of antibodies to thrombopoietinBlood, 2001
- In vivo cultivation of tumor cells in hollow fibersLife Sciences, 1995